Hydrocodone is significantly stronger than codeine. Milligram for milligram, hydrocodone is roughly six to seven times more potent as a painkiller. To put that in concrete terms, you’d need about 200 mg of codeine to match the pain relief from just 30 to 45 mg of hydrocodone.
How Their Potency Compares
The clearest way to compare opioid strength is through morphine equivalents, a standard scale that measures how much of any opioid provides the same pain relief as a set dose of morphine. On this scale, hydrocodone has a conversion factor of 1 (essentially equal to morphine), while codeine’s factor is just 0.15. That means 1 mg of hydrocodone provides about the same relief as 1 mg of oral morphine, while you’d need roughly 6.7 mg of codeine to match that same effect.
The World Health Organization’s analgesic potency table frames it slightly differently but reaches the same conclusion: hydrocodone is about two-thirds as potent as morphine, while codeine is only one-tenth as potent. Either way you measure it, hydrocodone delivers substantially more pain relief per milligram.
Why Codeine Is So Much Weaker
Codeine is what pharmacologists call a prodrug. On its own, it barely activates the brain’s opioid receptors. Morphine binds to those receptors with about 200 times greater affinity than codeine does. For codeine to actually relieve pain, your liver has to convert it into morphine first, using a specific enzyme called CYP2D6.
Here’s the catch: that conversion is remarkably inefficient. Only about 5 to 10 percent of a codeine dose gets converted to morphine. The remaining 80 percent or so breaks down into inactive compounds your body simply excretes. So most of the codeine you take never becomes the active painkiller your body needs. Hydrocodone, by contrast, acts directly on opioid receptors without depending on that same bottleneck conversion step.
Your Genetics Can Change the Equation
Because codeine relies so heavily on that single liver enzyme, your genetic makeup plays an outsized role in how well it works for you. People fall into distinct categories based on how many working copies of the CYP2D6 gene they carry, and the differences are dramatic.
If you have two inactive copies of the gene (roughly 5 to 10 percent of people of European descent), you’re considered a “poor metabolizer.” Codeine will provide little to no pain relief because your body can’t convert it to morphine effectively. For these people, codeine is essentially a sugar pill with side effects.
On the opposite end, “ultrarapid metabolizers” carry extra copies of the gene and convert codeine to morphine faster and more completely than normal. This can be genuinely dangerous. Even standard doses of codeine can flood these individuals with morphine, causing extreme drowsiness, confusion, and dangerously slow breathing. In some cases, this has been fatal. Hydrocodone’s effects are more predictable across different genetic profiles, which is one reason many prescribers prefer it.
How They Compare in Practice
Despite the large gap in potency per milligram, a head-to-head clinical trial comparing the two drugs (both combined with acetaminophen) in cancer patients with moderate to severe pain found that efficacy was comparable when each was dosed appropriately. The key phrase there is “dosed appropriately.” Codeine works fine for many people when given at higher milligram amounts to compensate for its lower potency. The issue isn’t that codeine can’t control pain; it’s that you need a lot more of it.
Side effects in that same trial were also similar between the two groups. Constipation was the most common complaint (36 percent with codeine versus 29 percent with hydrocodone), followed by dizziness (24 percent versus 19 percent) and vomiting (24 percent versus 16 percent). None of these differences reached statistical significance. Both drugs cause the typical opioid side effect profile: constipation, nausea, drowsiness, and dry mouth.
Scheduling and Common Formulations
Both codeine and hydrocodone are classified as Schedule II controlled substances by the DEA in their pure forms. However, codeine combination products containing no more than 90 mg per dosage unit (like Tylenol with Codeine) drop to Schedule III, and codeine cough preparations are Schedule V. Hydrocodone combination products were reclassified from Schedule III to Schedule II in 2014, reflecting growing concern about their abuse potential.
You’ll rarely encounter either drug alone. Hydrocodone is most commonly prescribed in combination with acetaminophen under brand names like Vicodin, Norco, and Lortab, or with ibuprofen as Vicoprofen. Codeine is typically combined with acetaminophen (Tylenol 3) or included in prescription cough syrups. The immediate-release form of hydrocodone reaches peak blood levels within about one hour, with doses typically taken every four to six hours.
What This Means for Pain Management
Codeine is generally reserved for mild to moderate pain and cough suppression, while hydrocodone is prescribed for moderate to moderately severe pain. If your doctor switches you from codeine to hydrocodone, it typically means your pain needs a stronger medication, not just a higher dose of the same class. The reverse is also true: if codeine controls your pain adequately, there’s no clinical reason to move to a more potent opioid.
The unpredictability of codeine’s metabolism is a real clinical limitation. Two patients given the same dose can have wildly different responses based on their genetics alone. Hydrocodone offers more consistent pain relief across different people, which is partly why it became one of the most prescribed opioids in the United States. That consistency, though, also contributed to widespread misuse, prompting its tighter scheduling controls.